Treatment with ProSense® resulted in 92.9% volume reduction of fibroadenoma one-year post-cryoablationFindings may impact treatment guidelines issued by ...
Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results